You are viewing the site in preview mode

Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: E2F2(E2F transcription factor 2) as a potential therapeutic target in meibomian gland carcinoma: evidence from functional and epigenetic studies

Fig. 5

Effects of E2F2 on Apoptosis and Cell Cycle in MGC Cells. a Flow cytometry analysis of cell apoptosis, with quantification based on the apoptosis rate. b, c RT-qPCR and Western blot analyses of the expression of apoptosis-related proteins Bax and Caspase-3. d Flow cytometry analysis of the distribution of cells across different phases of the cell cycle. e RT-qPCR analysis of the expression levels of cell cycle-related genes P16, P21, P27, and CDK4.*P < 0.05; **P < 0.01; ***P < 0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us